» Articles » PMID: 11382382

Long-term Alteration of Calcium Homeostatic Mechanisms in the Pilocarpine Model of Temporal Lobe Epilepsy

Overview
Journal Brain Res
Specialty Neurology
Date 2001 May 31
PMID 11382382
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

The pilocarpine model of temporal lobe epilepsy is an animal model that shares many of the clinical and pathophysiological characteristics of temporal lobe or limbic epilepsy in humans. This model of acquired epilepsy produces spontaneous recurrent seizure discharges following an initial brain injury produced by pilocarpine-induced status epilepticus. Understanding the molecular mechanisms mediating these long lasting changes in neuronal excitability would provide an important insight into developing new strategies for the treatment and possible prevention of this condition. Our laboratory has been studying the role of alterations in calcium and calcium-dependent systems in mediating some of the long-term neuroplasticity changes associated with epileptogenesis. In this study, [Ca(2+)](i) imaging fluorescence microscopy was performed on CA1 hippocampal neurons acutely isolated from control and chronically epileptic animals at 1 year after the induction of epileptogenesis with two different fluorescent dyes (Fura-2 and Fura-FF) having high and low affinities for [Ca(2+)](i). The high affinity Ca(2+) indicator Fura-2 was utilized to evaluate [Ca(2+)](i) levels up to 900 nM and the low affinity indicator Fura-FF was employed for evaluating [Ca(2+)](i) levels above this range. Baseline [Ca(2+)](i) levels and the ability to restore resting [Ca(2+)](i) levels after a brief exposure to several glutamate concentrations in control and epileptic neurons were evaluated. Epileptic neurons demonstrated a statistically significantly higher baseline [Ca(2+)](i) level in comparison to age-matched control animals. This alteration in basal [Ca(2+)](i) levels persisted up to 1 year after the induction of epileptogenesis. In addition, the epileptic neurons were unable to rapidly restore [Ca(2+)](i) levels to baseline following the glutamate-induced [Ca(2+)](i) loads. These changes in Ca(2+) regulation were not produced by a single seizure and were not normalized by controlling the seizures in the epileptic animals with anticonvulsant treatment. Peak [Ca(2+)](i) levels in response to different concentrations of glutamate were the same in both epileptic and control neurons. Thus, glutamate produced the same initial [Ca(2+)](i) load in both epileptic and control neurons. Characterization of the viability of acutely isolated neurons from control and epileptic animals utilizing standard techniques to identify apoptotic or necrotic neurons demonstrated that epileptic neurons had no statistically significant difference in viability compared to age-matched controls. These results provide the first direct measurement of [Ca(2+)](i) levels in an intact model of epilepsy and indicate that epileptogenesis in this model produced long-lasting alterations in [Ca(2+)](i) homeostatic mechanisms that persist for up to 1 year after induction of epileptogenesis. These observations suggest that altered [Ca(2+)](i) homeostatic mechanisms may underlie some aspects of the epileptic phenotype and contribute to the persistent neuroplasticity changes associated with epilepsy.

Citing Articles

Regulation of specific abnormal calcium signals in the hippocampal CA1 and primary cortex M1 alleviates the progression of temporal lobe epilepsy.

Chen F, Dong X, Wang Z, Wu T, Wei L, Li Y Neural Regen Res. 2023; 19(2):425-433.

PMID: 37488907 PMC: 10503629. DOI: 10.4103/1673-5374.379048.


Modulating Expression of Endogenous Interleukin 1 Beta in the Acute Phase of the Pilocarpine Model of Epilepsy May Change Animal Survival.

Pascoal V, Marchesini R, Athie M, Matos A, Conte F, Pereira T Cell Mol Neurobiol. 2022; 43(1):367-380.

PMID: 35061107 DOI: 10.1007/s10571-022-01190-y.


Calcium dysregulation and compensation in cortical pyramidal neurons of the R6/2 mouse model of Huntington's disease.

Oikonomou K, Donzis E, Bui M, Cepeda C, Levine M J Neurophysiol. 2021; 126(4):1159-1171.

PMID: 34469694 PMC: 8560428. DOI: 10.1152/jn.00181.2021.


Genetic Landscape of Common Epilepsies: Advancing towards Precision in Treatment.

Thakran S, Guin D, Singh P, Singh P, Kukal S, Rawat C Int J Mol Sci. 2020; 21(20).

PMID: 33096746 PMC: 7589654. DOI: 10.3390/ijms21207784.


Novel therapeutics for treating organophosphate-induced status epilepticus co-morbidities, based on changes in calcium homeostasis.

Deshpande L, DeLorenzo R Neurobiol Dis. 2019; 133:104418.

PMID: 30872159 PMC: 6742584. DOI: 10.1016/j.nbd.2019.03.006.